Seqster Launches Real World Data Tools on Salesforce AppExchange
By Clinical Research News Staff
April 12, 2022 | Seqster PDM has launched SeqsterOS, the operating system for patient registries and clinical studies on Salesforce AppExchange integrated directly with Salesforce Health Cloud. SeqsterOS seeks to empower life science enterprises to seamlessly integrate patient-consented Real World Data, including electronic health records (EHR), genomics, and device data, with a patient engagement layer for their clinical studies.
SeqsterOS automates real-time Real World Data (RWD) collection while improving the participant journey. Life science enterprises benefit from improved study participant engagement and retention. Study participants and researchers benefit from longitudinal health information essential for long-term observational studies and effectively conducting health economics & outcomes research (HEOR).
SeqsterOS on Health Cloud offers these additional benefits:
- FDA 21 CFR Part 11 Compliance for drug submissions
- De-identification and tokenization of data
- E-Consent, eCOA
“SeqsterOS empowers researchers with high-quality, high-fidelity health data directly from any source that can be readily utilized for analytics, AI, and RWE, accelerating the drug discovery cycle, all while improving the patient journey,” said Ardy Arianpour, CEO & Co-Founder of Seqster, in a press release. “By joining Salesforce AppExchange, we introduce our solution at scale for life science enterprise clients for application in clinical studies, whether in the traditional site-based setting or in decentralized trials.”